Plasma sex hormone levels and mortality in disabled older men and women

Geriatrics and Gerontology International

Volumn 11, Issue 2, 2011, Pages 196-203

  Fukai, Shiho ^a   Akishita, Masahiro ^a   Yamada, Shizuru ^b   Ogawa, Sumito ^a   Yamaguchi, Kiyoshi ^a   Kozaki, Koichi ^b   Toba, Kenji ^b   Ouchi, Yasuyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dehydroepiandrosterone; Disabled elderly; Mortality risk; Testosterone

Indexed keywords

ESTRADIOL; PRASTERONE SULFATE; TESTOSTERONE;

AGED; ARTICLE; CANCER MORTALITY; CHRONIC DISEASE; DISABLED PERSON; ELDERLY CARE; FEMALE; FUNCTIONAL STATUS; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; ANDROGENS; DEHYDROEPIANDROSTERONE SULFATE; DISABLED PERSONS; FEMALE; HUMANS; JAPAN; LONGEVITY; MALE; MORTALITY; RISK FACTORS; TESTOSTERONE;

EID: 79952734460     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2010.00670.x     Document Type: Article

References (42)

1. UN. World population prospects: the 2008 revision. [Cited 1 Mar 2010.] Available from URL.
2. Statistics and Information Department Minister's Secretariat Ministry of Health, Labour and Welfare Japanese Government. Abridged life tables for Japan. 2008 Ministry of Health, Labour and Welfare. [Cited 1 Mar 2010.] Available from URL.
3. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006; 166: 1660-1665.
4. Khaw KT, Dowsett M, Folkerd E etal. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007; 116: 2694-2701.
5. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008; 93: 68-75.
6. Shores MM, Moceri VM, Gruenewald DA, Brodkin KI, Matsumoto AM, Kivlahan DR. Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in geriatric rehabilitation unit. J Am Geriatr Soc 2004; 52: 2077-2081.
7. Tivesten A, Vandenput L, Labrie F etal. Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab 2009; 94: 2482-2488.
8. Vikan T, Schirmer H, Njølstad I, Svartberg J. Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. Eur J Endocrinol 2009; 161: 435-442.
9. Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, van der Schouw YT. Endogenous sex hormones in men aged 40-80years. Eur J Endocrinol 2003; 149: 583-589.
10. Schaap LA, Pluijm SM, Smit JH etal. The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. J Clin Endocrinol 2005; 63: 152-160.
11. O'Donnell AB, Travison TG, Harris SS, Tenover JL, McKinlay JB. Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachussetts Male Aging Study. J Clin Endocrinol Metab 2006; 91: 425-431.
12. Orwoll E, Lambert LC, Marshall LM etal. Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med 2006; 166: 2124-2131.
13. Fink HA, Ewing SK, Ensrud KE etal. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 2006; 91: 3908-3915.
14. Meier C, Nguyen TV, Handelsman DJ etal. Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 2008; 168: 47-54.
15. Almeida OP, Yeap BB, Hankey GJ, Jamrozik K, Flicker L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry 2008; 65: 283-289.
16. Yaffe K, Lui LY, Zmuda J, Cauley J. Sex hormones and cognitive function in older men. J Am Geriatr Soc 2002; 50: 707-712.
17. Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 2002; 87: 5001-5007.
18. Yeap BB, Beilin J, Shi Z etal. Serum testosterone levels correlate with haemoglobin in middle-aged and older men. Intern Med J 2009; 39: 532-538.
19. Ferrucci L, Maggio M, Bandinelli S etal. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006; 166: 1380-1388.
20. Cawthon PM, Ensrud KE, Laughlin GA etal. Osteoporotic Fractures in Men (MrOS) Research Group. Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab 2009; 94: 3806-3815.
21. Fukai S, Akishita M, Yamada S etal. Association of plasma sex hormone levels with functional decline in elderly men and women. Geriatr Gerontol Int 2009; 9: 282-289.
22. Labrie F. Adrenal androgens and intracrinology. Semin Reprod Med 2004; 22: 299-309.
23. Arlt W. Androgen therapy in women. Eur J Endocrinol 2006; 154: 1-11.
24. Davis SR, Shah SM, McKenzie DP, Kulkarni J, Davison SL, Bell RJ. Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab 2008; 93: 801-808.
25. Barrett-Connor E, von Mühlen D, Laughlin GA, Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc 1999; 47: 685-691.
26. Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res 1997; 12: 1833-1843.
27. Voznesensky M, Walsh S, Dauser D, Brindisi J, Kenny AM. The association between dehydroepiandosterone and frailty in older men and women. Age Ageing 2009; 38: 401-406.
28. Cappola AR, Xue QL, Walston JD etal. DHEAS levels and mortality in disabled older women: the Women's Health and Aging Study I. J Gerontol A Biol Sci Med Sci 2006; 61: 957-962.
29. Glei DA, Goldman N. Dehydroepiandrosterone sulfate (DHEAS) and risk for mortality among older Taiwanese. Ann Epidemiol 2006; 16: 510-515.
30. Mazat L, Lafont S, Berr C etal. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci U S A 2001; 98: 8145-8150.
31. Trivedi DP, Khaw KT. Dehydroepiandrosterone sulfate and mortality in elderly men and women. J Clin Endocrinol Metab 2001; 86: 4171-4177.
32. Cappola AR, O'Meara ES, Guo W, Bartz TM, Fried LP, Newman AB. Trajectories of dehydroepiandrosterone sulfate predict mortality in older adults: the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci 2009; 64: 1268-1274.
33. Mahoney FI, Barthel DW. Functional evaluation: Barthel Index. Md State Med J 1965; 14: 61-65.
34. Kato S, Shimogaki M, Onodera H etal. Revised Hasegawa Dementia Scale (HDS-R). Jpn J Geriatr Psychiatr 1991; 2: 1339-1347.
35. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull 1988; 24: 709-711.
36. Toba K, Nakai R, Akishita M etal. Vitality Index as a useful tool to assess elderly with dementia. Geriatr Gerontol Int 2002; 2: 23-29.
37. World Health Organization. International Statistical Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization, Version for 2007.
38. Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, Elwood P. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 2005; 112: 332-340.
39. Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, McKinlay JB. Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med 2007; 167: 1252-1260.
40. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002; 57A: M76-M99.
41. Barrett-Connor E, Khaw KT, Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986; 315: 1519-1524.
42. Dillon JS. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr Drug Targets Inflamm Allergy 2005; 4: 377-385.